EX-99.3 4 d867288dex993.htm EX-99.3 EX-99.3

Exhibit 99.3

 

 

 

LOGO

NUTRIEN LTD.

INTERIM FINANCIAL STATEMENTS AND NOTES

AS AT AND FOR THE THREE AND SIX MONTHS ENDED

JUNE 30, 2024


Unaudited  

 

Condensed Consolidated Financial Statements

Condensed Consolidated Statements of Earnings

 

          

Three Months Ended

June 30

   

Six Months Ended

June 30

 
 (millions of US dollars, except as otherwise noted)    Note     2024     2023     2024     2023  

SALES

     2, 10       10,156       11,654       15,545       17,761  

 Freight, transportation and distribution

       240       252       478       451  

 Cost of goods sold

             7,004       8,236       10,618       12,231  

 GROSS MARGIN

       2,912       3,166       4,449       5,079  

 Selling expenses

       1,008       979       1,802       1,749  

 General and administrative expenses

       158       157       312       302  

 Provincial mining taxes

       68       104       136       223  

 Share-based compensation expense (recovery)

       10       (64     16       (49

 Impairment of assets

     3       530       698       530       698  

 Foreign exchange loss, net of related derivatives

     6       285       52       328       18  

 Other expenses

     4       9       112       62       71  

EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES

 

    844       1,128       1,263       2,067  

 Finance costs

             162       204       341       374  

EARNINGS BEFORE INCOME TAXES

       682       924       922       1,693  

 Income tax expense

     5       290       476       365       669  

NET EARNINGS

             392       448       557       1,024  

 Attributable to

          

 Equity holders of Nutrien

       385       440       543       1,011  

 Non-controlling interest

             7       8       14       13  

NET EARNINGS

             392       448       557       1,024  

NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN (“EPS”)

 

               

 Basic

       0.78       0.89       1.10       2.03  

 Diluted

             0.78       0.89       1.10       2.03  

 Weighted average shares outstanding for basic EPS

       494,646,000       495,379,000       494,608,000       498,261,000  

 Weighted average shares outstanding for diluted EPS

             494,915,000       495,932,000       494,851,000       499,059,000  
Condensed Consolidated Statements of Comprehensive Income

 

           Three Months Ended
June 30
    Six Months Ended
June 30
 
 (millions of US dollars)           2024     2023     2024     2023  

NET EARNINGS

       392       448       557       1,024  

 Other comprehensive income (loss)

          

 Items that will not be reclassified to net earnings:

          

 Net actuarial loss on defined benefit plans

       -       -       -       (3

 Net fair value gain on investments

       36       6       18       11  

 Items that have been or may be subsequently reclassified to net earnings:

          

 Gain (loss) on currency translation of foreign operations

       9       49       (57     50  

 Other

             (1     13       (19     12  

OTHER COMPREHENSIVE INCOME (LOSS)

             44       68       (58     70  

COMPREHENSIVE INCOME

             436       516       499       1,094  

 Attributable to

          

 Equity holders of Nutrien

       429       508       486       1,081  

 Non-controlling interest

             7       8       13       13  

COMPREHENSIVE INCOME

             436       516       499       1,094  

 

(See

Notes to the Condensed Consolidated Financial Statements)

 

25


Unaudited  

 

Condensed Consolidated Statements of Cash Flows

 

            Three Months Ended
June 30
     Six Months Ended
June 30
 
 (millions of US dollars)    Note      2024      2023      2024      2023  
                   Note 1             Note 1  

 OPERATING ACTIVITIES

              

 Net earnings

        392        448        557        1,024  

 Adjustments for:

              

 Depreciation and amortization

        586        556        1,151        1,052  

 Share-based compensation expense (recovery)

        10        (64      16        (49

 Impairment of assets

     3        530        698        530        698  

 Provision for deferred income tax

        23        100        51        121  

 Net distributed (undistributed) earnings of equity-accounted investees

        88        (23      38        140  

 Fair value adjustment to derivatives

     6        187        38        186        32  

 Loss related to financial instruments in Argentina

     4        15        92        34        92  

 Long-term income tax receivables and payables

        (35      (18      8        (90

 Other long-term assets, liabilities and miscellaneous

              5        53        70        (14

 Cash from operations before working capital changes

        1,801        1,880        2,641        3,006  

 Changes in non-cash operating working capital:

              

 Receivables

        (2,555      (2,653      (2,812      (2,118

 Inventories and prepaid expenses and other current assets

        3,222        4,065        1,892        2,572  

 Payables and accrued charges

              (661      (1,049      (401      (2,075

CASH PROVIDED BY OPERATING ACTIVITIES

              1,807        2,243        1,320        1,385  

INVESTING ACTIVITIES

              

 Capital expenditures 1

        (547      (791      (920      (1,256

 Business acquisitions, net of cash acquired

        (4      (5      (4      (116

 Net proceeds from (purchase of) investments

        3        (93      (15      (98

 Purchase of investments

        (107      -        (111      -    

 Net changes in non-cash working capital

        5        (4      (85      (104

 Other

              36        35        27        22  

CASH USED IN INVESTING ACTIVITIES

              (614      (858      (1,108      (1,552

FINANCING ACTIVITIES

              

 (Net repayment of) proceeds from debt

        (1,215      (1,105      (289      768  

 Proceeds from debt

        998        -          998        1,500  

 Repayment of debt

        (75      (500      (89      (517

 Repayment of principal portion of lease liabilities

        (106      (100      (202      (187

 Dividends paid to Nutrien’s shareholders

        (266      (263      (527      (509

 Repurchase of common shares

        -          (150      -          (1,047

 Issuance of common shares

        8        3        9        31  

 Other

              (28      (9      (36      (34

CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES

              (684      (2,124      (136      5  

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

              (1      3        (13      (2

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

        508        (736      63        (164

CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD

              496        1,473        941        901  

CASH AND CASH EQUIVALENTS – END OF PERIOD

              1,004        737        1,004        737  

 Cash and cash equivalents is composed of:

              

 Cash

                953                724                953                724  

 Short-term investments

              51        13        51        13  
                1,004        737        1,004        737  

SUPPLEMENTAL CASH FLOWS INFORMATION

              

 Interest paid

        216        227        348        325  

 Income taxes paid

        83        270        133        1,589  

 Total cash outflow for leases

              153        129        284        248  

 1 Includes additions to property, plant and equipment, and intangible assets for the three months ended June 30, 2024 of $506 million and $41 million (2023 – $732 million and $59 million), respectively, and for the six months ended June 30, 2024 of $844 million and $76 million (2023 – $1,154 million and $102 million), respectively.

(See Notes to the Condensed Consolidated Financial Statements)

 

26


Unaudited  

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

                      Accumulated Other Comprehensive
(Loss) Income (“AOCI”)
                         
 (millions of US dollars, except as otherwise noted)   Number of
Common
Shares
    Share
Capital
    Contributed
Surplus
    (Loss) Gain
on Currency
Translation
of Foreign
Operations
    Other     Total
AOCI
    Retained
Earnings
    Equity
Holders
of
Nutrien
    Non-
Controlling
Interest
    Total
Equity
 
           

 BALANCE – DECEMBER 31, 2022

    507,246,105       14,172       109       (374     (17     (391     11,928       25,818       45       25,863  
           

 Net earnings

    -       -       -       -       -       -       1,011       1,011       13       1,024  
           

 Other comprehensive income

    -       -       -       50       20       70       -       70       -       70  
           

 Shares repurchased

    (13,378,189     (374     (26     -       -       -       (600     (1,000     -       (1,000
           

 Dividends declared - $1.06/share

    -       -       -       -       -       -       (527     (527     -       (527
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (13     (13

 Effect of share-based compensation including issuance of common shares

    628,402       37       (3     -       -       -       -       34       -       34  

 Transfer of net gain on sale of investment

    -       -       -       -       (14     (14     14       -       -       -  

 Transfer of net loss on cash flow hedges

    -       -       -       -       9       9       -       9       -       9  

 Transfer of net actuarial loss on defined benefit plans

    -       -       -       -       3       3       (3     -       -       -  

 Other

    -       -       -       (2     -       (2     -       (2     -       (2
           

 BALANCE – JUNE 30, 2023

    494,496,318       13,835       80       (326     1       (325     11,823       25,413       45       25,458  
           

 BALANCE – DECEMBER 31, 2023

    494,551,730       13,838       83       (286     (10     (296     11,531       25,156       45       25,201  
           

 Net earnings

    -       -       -       -       -       -       543       543       14       557  
           

 Other comprehensive loss

    -       -       -       (56     (1     (57     -       (57     (1     (58
           

 Dividends declared - $1.08/share

    -       -       -       -       -       -       (532     (532     -       (532
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (26     (26
           

 Effect of share-based compensation including issuance of common shares

    153,808       8       3       -       -       -       -       11       -       11  
           

 Transfer of net loss on cash flow hedges

    -       -       -       -       8       8       -       8       -       8  

 Other

    -       -       -       (2     -       (2     -       (2     -       (2
         

 BALANCE – JUNE 30, 2024

    494,705,538       13,846       86       (344     (3     (347     11,542       25,127       32       25,159  

 (See Notes to the Condensed Consolidated Financial Statements)

 

27


Unaudited  

 

Condensed Consolidated Balance Sheets

 

          June 30            December 31  
As at (millions of US dollars)    Note        2024          2023              2023  

ASSETS

             

Current assets

             

Cash and cash equivalents

        1,004        737          941  

Receivables

   6, 7, 10      8,123        8,595          5,398  

Inventories

        5,298        6,062          6,336  

Prepaid expenses and other current assets

          663        602          1,495  
        15,088        15,996          14,170  

Non-current assets

             

Property, plant and equipment

        22,198        21,920          22,461  

Goodwill

        12,094        12,077          12,114  

Intangible assets

        1,912        2,252          2,217  

Investments

        703        708          736  

Other assets

          996        973          1,051  

TOTAL ASSETS

          52,991        53,926          52,749  

LIABILITIES

             

Current liabilities

             

Short-term debt

   7      1,571        2,922          1,815  

Current portion of long-term debt

        1,012        44          512  

Current portion of lease liabilities

        364        301          327  

Payables and accrued charges

   6      9,024        9,470          9,467  
        11,971        12,737          12,121  

Non-current liabilities

             

Long-term debt

        9,399        9,498          8,913  

Lease liabilities

        1,024        861          999  

Deferred income tax liabilities

        3,615        3,584          3,574  

Pension and other post-retirement benefit liabilities

        245        245          252  

Asset retirement obligations and accrued environmental costs

        1,406        1,379          1,489  

Other non-current liabilities

          172        164          200  

TOTAL LIABILITIES

          27,832        28,468          27,548  

SHAREHOLDERS’ EQUITY

             

Share capital

        13,846        13,835          13,838  

Contributed surplus

        86        80          83  

Accumulated other comprehensive loss

        (347      (325        (296

Retained earnings

          11,542        11,823          11,531  

Equity holders of Nutrien

        25,127        25,413          25,156  

Non-controlling interest

          32        45          45  

TOTAL SHAREHOLDERS’ EQUITY

          25,159        25,458          25,201  

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

          52,991        53,926          52,749  

(See Notes to the Condensed Consolidated Financial Statements)

 

28


Unaudited  

 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Six Months Ended June 30, 2024

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading provider of crop inputs and services. Nutrien plays a critical role in helping growers around the globe increase food production in a sustainable manner.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2023 annual audited consolidated financial statements, as well as any amended standards adopted in 2024 that we previously disclosed. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2023 annual audited consolidated financial statements. Certain immaterial 2023 figures have been reclassified in the condensed consolidated statements of earnings, condensed consolidated statements of cash flows and Note 4 Other expenses (income).

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year. These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on August 7, 2024.

Note 2 Segment information

We have four reportable operating segments: Nutrien Ag Solutions (“Retail”), Potash, Nitrogen and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seed and merchandise. Retail provides services directly to growers through a network of farm centers in North America, South America and Australia. The Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each produces. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

 

             
 (millions of US dollars)   Retail      Potash      Nitrogen      Phosphate     

 

Corporate
and Others

     Eliminations     Consolidated  

 Assets – as at June 30, 2024

    23,223        13,667        11,571        2,452        2,955        (877     52,991  

 Assets – as at December 31, 2023

    23,056        13,571        11,466        2,438        2,818        (600     52,749  

 

29


Unaudited  

 

    Three Months Ended June 30, 2024  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

    8,074       750       948       384       -       -       10,156  

        – intersegment

    -       86       239       67       -       (392     -  

 Sales   – total

    8,074       836       1,187       451       -       (392     10,156  

 Freight, transportation and distribution

    -       80       159       57       -       (56     240  

 Net sales

    8,074       756       1,028       394       -       (336     9,916  

 Cost of goods sold

    6,045       359       650       361       -       (411     7,004  

 Gross margin

    2,029       397       378       33       -       75       2,912  

 Selling expenses (recovery)

    1,005       3       8       2       (3     (7     1,008  

 General and administrative expenses

    51       1       5       3       98       -       158  

 Provincial mining taxes

    -       68       -       -       -       -       68  

 Share-based compensation expense

    -       -       -       -       10       -       10  

 Impairment of assets

    335       -       195       -       -       -       530  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       285       -       285  

 Other expenses (income)

    41       4       (78 )       8       26       8       9  

 Earnings (loss) before finance costs and income taxes

    597       321       248       20       (416     74       844  

 Depreciation and amortization

    196       151       151       68       20       -       586  

 EBITDA

    793       472       399       88       (396     74       1,430  

 Share-based compensation expense

    -       -       -       -       10       -       10  

 Impairment of assets

    335       -       195       -       -       -       530  

 Loss related to financial instruments in Argentina

    -       -       -       -       15       -       15  

 ARO/ERL related income for non-operating sites

    -       -       -       -       (35     -       (35

 Foreign exchange loss, net of related derivatives

    -       -       -       -       285       -       285  

 Adjusted EBITDA

    1,128       472       594       88       (121     74       2,235  
    Three Months Ended June 30, 2023  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

    9,127       976       1,065       486       -       -       11,654  

        – intersegment

    1       140       306       74       -       (521     -  

 Sales   – total

    9,128       1,116       1,371       560       -       (521     11,654  

 Freight, transportation and distribution

    -       107       155       58       -       (68     252  

 Net sales

    9,128       1,009       1,216       502       -       (453     11,402  

 Cost of goods sold

    7,197       353       817       453       -       (584     8,236  

 Gross margin

    1,931       656       399       49       -       131       3,166  

 Selling expenses (recovery)

    971       3       7       2       (2     (2     979  

 General and administrative expenses

    55       5       5       4       88       -       157  

 Provincial mining taxes

    -       104       -       -       -       -       104  

 Share-based compensation recovery

    -       -       -       -       (64     -       (64

 Impairment of assets

    465       -       -       233       -       -       698  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       52       -       52  

 Other expenses (income)

    29       5       (20     1       99       (2     112  

 Earnings (loss) before finance costs and income taxes

    411       539       407       (191     (173     135       1,128  

 Depreciation and amortization

    188       115       162       71       20       -       556  

 EBITDA

    599       654       569       (120     (153     135       1,684  

 Integration and restructuring related costs

    3       -       -       -       7       -       10  

 Share-based compensation recovery

    -       -       -       -       (64     -       (64

 Impairment of assets

    465       -       -       233       -       -       698  

 Loss related to financial instruments in Argentina

    -       -       -       -       92       -       92  

 ARO/ERL related expense for non-operating sites

    -       -       -       -       6       -       6  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       52       -       52  

 Adjusted EBITDA

    1,067       654       569       113       (60     135       2,478  

 

30


Unaudited  

 

    Six Months Ended June 30, 2024  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

    11,382       1,571       1,794       798       -       -       15,545  

        – intersegment

    -       192       421       152       -       (765     -  

 Sales   – total

    11,382       1,763       2,215       950       -       (765     15,545  

 Freight, transportation and distribution

    -       194       276       119       -       (111     478  

 Net sales

    11,382       1,569       1,939       831       -       (654     15,067  

 Cost of goods sold

    8,606       717       1,254       733       -       (692     10,618  

 Gross margin

    2,776       852       685       98       -       38       4,449  

 Selling expenses (recovery)

    1,795       6       15       4       (5     (13     1,802  

 General and administrative expenses

    103       5       10       7       187       -       312  

 Provincial mining taxes

    -       136       -       -       -       -       136  

 Share-based compensation expense

    -       -       -       -       16       -       16  

 Impairment of assets

    335       -       195       -       -       -       530  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       328       -       328  

 Other expenses (income)

    63       1       (111     16       80       13       62  

 Earnings (loss) before finance costs and income taxes

    480       704       576       71       (606     38       1,263  

 Depreciation and amortization

    390       298       287       138       38       -       1,151  

 EBITDA

    870       1,002       863       209       (568     38       2,414  

 Share-based compensation expense

    -       -       -       -       16       -       16  

 Impairment of assets

    335       -       195       -       -       -       530  

 Loss related to financial instruments in Argentina

    -       -       -       -       34       -       34  

 ARO/ERL related income for non-operating sites

    -       -       -       -       (32     -       (32

 Foreign exchange loss, net of related derivatives

    -       -       -       -       328       -       328  

 Adjusted EBITDA

    1,205       1,002       1,058       209       (222     38       3,290  
    Six Months Ended June 30, 2023  
 (millions of US dollars)   Retail     Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales   – third party

    12,549       1,999       2,219       994       -       -       17,761  

        – intersegment

    1       194       570       138       -       (903     -  

 Sales   – total

    12,550       2,193       2,789       1,132       -       (903     17,761  

 Freight, transportation and distribution

    -       182       261       116       -       (108     451  

 Net sales

    12,550       2,011       2,528       1,016       -       (795     17,310  

 Cost of goods sold

    10,004       658       1,588       880       -       (899     12,231  

 Gross margin

    2,546       1,353       940       136       -       104       5,079  

 Selling expenses

    1,736       6       15       4       (4     (8     1,749  

 General and administrative expenses

    105       8       10       7       172       -       302  

 Provincial mining taxes

    -       223       -       -       -       -       223  

 Share-based compensation recovery

    -       -       -       -       (49     -       (49

 Impairment of assets

    465       -       -       233       -       -       698  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       18       -       18  

 Other expenses (income)

    44       (2     (34 )       13       52       (2     71  

 Earnings (loss) before finance costs and income taxes

    196       1,118       949       (121     (189     114       2,067  

 Depreciation and amortization

    369       212       296       138       37       -       1,052  

 EBITDA

    565       1,330       1,245       17       (152     114       3,119  

 Integration and restructuring related costs

    3       -       -       -       12       -       15  

 Share-based compensation recovery

    -       -       -       -       (49     -       (49

 Impairment of assets

    465       -       -       233       -       -       698  

 Loss related to financial instruments in Argentina

    -       -       -       -       92       -       92  

 ARO/ERL related expense for non-operating sites

    -       -       -       -       6       -       6  

 Foreign exchange loss, net of related derivatives

    -       -       -       -       18       -       18  

 Adjusted EBITDA

    1,033       1,330       1,245       250       (73     114       3,899  

 

31


Unaudited  

 

   

Three Months Ended

June 30

   

Six Months Ended

June 30

 
(millions of US dollars)   2024     2023     2024     2023  

 Retail sales by product line

       

Crop nutrients

    3,281       3,986       4,590       5,321  

Crop protection products

    2,733       3,070       3,847       4,224  

Seed

    1,434       1,428       1,919       1,935  

Services and other

    292       308       448       456  

Merchandise

    245       273       445       519  

Nutrien Financial

    133       122       199       179  

Nutrien Financial elimination 1

    (44     (59     (66     (84
      8,074       9,128       11,382       12,550  

 Potash sales by geography

       

Manufactured product

       

North America

    353       577       873       994  

Offshore 2

    482       539       889       1,199  

Other potash and purchased products

    1       -       1       -  
      836       1,116       1,763       2,193  

 Nitrogen sales by product line

       

Manufactured product

       

Ammonia

    351       389       595       805  

Urea and ESN®

    426       490       792       981  

Solutions, nitrates and sulfates

    343       381       662       752  

Other nitrogen and purchased products

    67       111       166       251  
      1,187       1,371       2,215       2,789  

 Phosphate sales by product line

       

Manufactured product

       

Fertilizer

    291       289       612       591  

Industrial and feed

    155       189       322       384  

Other phosphate and purchased products

    5       82       16       157  
      451       560       950       1,132  

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2 Relates to Canpotex Limited (“Canpotex”) (Note 10) and includes provisional pricing adjustments for the three months ended June 30, 2024 of $(1) million (2023 – $(173) million) and the six months ended June 30, 2024 of $11 million (2023 – $(320) million).

Note 3 Impairment of assets

We recorded the following non-cash impairment of assets in the condensed consolidated statements of earnings:

 

          Three and Six Months Ended
June 30
Segment    Category (millions of US dollars)       2024       2023 

 Retail

   Intangible assets    200     43 
   Property, plant and equipment    120     - 
   Other    15     - 
   Goodwill    -     422 

 Nitrogen

   Property, plant and equipment    195     - 

 Phosphate

  

Property, plant and equipment

   -     233 

 Impairment of assets

   530     698 

Retail – Brazil

At June 30, 2024, due to the ongoing market instability and more moderate margin expectations, we have lowered our forecasted EBITDA for the Retail – Brazil cash generating unit (“CGU”). This triggered an impairment analysis. Prior to June 30, 2023, the Retail – Brazil CGU was part of the Retail – South America group of CGUs at which time the goodwill of the group was deemed to be fully impaired.

We used the fair value less cost to dispose (“FVLCD”) methodology (level 3) based on a market approach to assess the recoverable value of the Retail – Brazil CGU at June 30, 2024. This is a change from our 2023 analysis, as the market approach resulted in a more representative fair value of the CGU as restructuring initiatives in Brazil are currently being developed. In 2023, we used the

 

32


Unaudited  

 

FVLCD methodology based on after-tax discounted cash flows (10-year projections plus a terminal value) and an after-tax discount rate (14.4 percent). We incorporated assumptions that an independent market participant would apply.

The key assumptions with the greatest influence on the calculation of the impairment are the estimated recoverable value of property, plant and equipment and intangible assets. Any change to these estimates could directly impact the impairment amount.

 

 (millions of US dollars)    Retail – Brazil
June 30, 2024
 

 Recoverable amount comprised of:

  

Working capital and other

     324  

Property, plant and equipment

     92  

Intangible assets

     -  

Nitrogen

During the three and six months ended June 30, 2024, we decided that we are no longer pursuing our Geismar Clean Ammonia project. As a result, we recorded an impairment loss of $195 million to fully write-off the amount of property, plant and equipment related to this project. As the project was cancelled before it generated revenue, the recoverable amount, which was based on its value in use, is $nil.

At June 30, 2023, we recorded an impairment of $465 million on our Retail – South America groups of CGUs and $233 million on our Phosphate – White Springs CGU. Refer to Note 13 of our 2023 annual audited consolidated financial statements for further details.

Note 4 Other expenses (income)

 

                                                           
    

Three Months Ended

June 30

    

Six Months Ended

June 30

 
 (millions of US dollars)        2024         2023           2024         2023   

 Integration and restructuring related costs

     -         10         -         15   

 Earnings of equity-accounted investees

     (30)        (35)        (81)        (72)  

 Bad debt expense

     50         30         63         39   

 Project feasibility costs

     28         21         43         34   

 Customer prepayment costs

     15         12         31         26   

 Insurance recoveries

     (67)        -         (67)        -   

 (Gain) loss on natural gas derivatives not designated as hedge ¹

     (1)        -         2         -   

 Loss related to financial instruments in Argentina

     15         92         34         92   

 ARO/ERL related (income) expenses for non-operating sites ²

     (35)        6         (32)        6   

 Gain on amendments to other post-retirement pension plans

     -         -         -         (80)  

 Other expenses (income)

     34         (24)        69         11   
       9         112         62         71   

1 Includes realized loss of $2 million for the three and six months ended June 30, 2024 (2023 – $nil) and unrealized gain of $3 million and $nil for the three and six months ended June 30, 2024, respectively (2023 – $nil).

2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

Argentina has certain currency controls in place that limit our ability to settle our foreign currency-denominated obligations or remit cash out of Argentina. We utilize various financial instruments such as Blue Chip Swaps or Bonds for the Reconstruction of a Free Argentina (“BOPREAL”) that effectively allow companies to transact in US dollars. We incurred losses on these transactions due to the significant divergence between the market exchange rate used for these financial instruments and the official Central Bank of Argentina rate. These losses are recorded as part of loss related to financial instruments in Argentina.

Note 5 Income taxes

A separate estimated average annual effective income tax rate was determined and applied individually to the interim period pre-tax earnings for each taxing jurisdiction.

 

                                                           
    

Three Months Ended

June 30

    

Six Months Ended

June 30

 
 (millions of US dollars, except as otherwise noted)        2024         2023           2024         2023   

 Actual effective tax rate on earnings (%)

     46         39         42         32   

 Actual effective tax rate including discrete items (%)

     43         51         40         40   

 Discrete tax adjustments that impacted the tax rate

     (23)        114         (20)        132   

 

33


Unaudited  

 

Note 6 Financial instruments

Foreign Currency Derivatives

The following table presents the significant foreign currency derivatives outstanding at the periods presented.

 

     As at June 30, 2024      As at December 31, 2023  
(millions of US dollars, except as
otherwise noted)
   Notional      Maturities
(year)
     Average
Contract
Rate
(1:1)
     Fair
Value 1
     Notional      Maturities
(year)
     Average
Contract
Rate
(1:1)
    

Fair 

Value 1

 

 Derivatives not designated as hedges

                       

Forwards (Sell/buy)

                       

USD/Brazilian real (“BRL”)

     2,065        July 2024        5.2208        (138      -        -        -        -   

USD/Canadian dollars (“CAD”)

     801        2024        1.3686        -        435        2024        1.3207        -   

Australian dollars/USD

     46        2024        1.5096        -        86        2024        1.5269        (5)  

BRL/USD

     -        -        -        -        94        2024        4.8688        -   

Options

                       

USD/BRL – sell USD calls

     600        July 2024        5.1772        (45      -        -        -        -   

USD/BRL – buy USD puts

     600        July 2024        5.1772        -        -        -        -        -   

 Derivatives designated as hedges

                       

Forwards (Sell/buy)

                       

USD/CAD

     681        2025        1.3605        (2      601        2024        1.3565        16   

 Presented as:

                       

Receivables

              -                 16   

Payables and accrued charges

                                (185                                 (5)  

1 Fair value of foreign currency derivatives are based on exchange-quoted prices which are classified as Level 2.

Subsequent to the June 30, 2024 reporting period, we entered into $3 billion notional value of BRL/USD (sell/buy) forward contracts, not designated as hedges. These contracts have maturity dates between July and September 2024 at an average contract rate of 5.62. An additional loss of approximately $12 million on foreign currency derivatives at fair value through profit or loss was recorded in July 2024. As of the issuance date of this report, all derivative contracts related to Brazil were settled except for $220 million notional value BRL/USD (sell/buy) of forward contracts as part of our ongoing risk management strategy.

 

    

Three Months Ended

June 30

    

Six Months Ended

June 30

 
 (millions of US dollars)        2024         2023           2024         2023   

 Foreign exchange loss (gain)

     40         (4)        30         (20)  

 Hyperinflationary loss

     20         19         65         32   

 Loss on foreign currency derivatives at fair value through profit or loss

     225         37         233         6   

 Foreign exchange loss, net of related derivatives

     285         52         328         18   

Natural Gas Derivatives

In 2024, we increased our use of natural gas derivatives to lock-in commodity prices. Our risk management strategies and accounting policies for derivatives that are designated and qualify as cash flow hedges are consistent with those disclosed in Note 10 and Note 30 of our annual consolidated financial statements, respectively. For derivatives that do not qualify as cash flow hedges, any gains or losses are recorded in net earnings in the current period.

We assess whether our derivative hedging transactions are expected to be or were highly effective, both at the hedge’s inception and on an ongoing basis, in offsetting changes in fair values of hedged items.

 

Hedging Transaction  

   Measurement of Ineffectiveness         

Potential Sources of Ineffectiveness

New York Mercantile Exchange (“NYMEX”) natural gas hedges    Assessed on a prospective and retrospective basis using regression analyses   

Changes in:

 timing of forecast transactions

 volume delivered

 our credit risk or the credit risk of  a counterparty 

 

34


Unaudited  

 

The table below presents information about our natural gas derivatives which are used to manage the risk related to significant price changes in natural gas.

 

    As at June 30, 2024  
 (millions of US dollars, except as otherwise noted)   Notional 1    

Maturities

(year)

   

Average

Contract Price 2

   

Fair Value of

Assets (Liabilities) 3

 

 Derivatives not designated as hedges

       

NYMEX call options

    29       2024       2.89       6  

 Derivatives designated as hedges

       

NYMEX swaps

    25       2024       2.84       1  

 1 In millions of Metric Million British Thermal Units (“MMBtu”).

 2 US dollars per MMBtu.

 3 Fair value of natural gas derivatives are based on a discounted cash flow model which are classified as Level 2.

Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt that has a carrying value of $10,411 million and fair value of $9,774 million as of June 30, 2024. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 7 Short-term debt

On March 7, 2024, we entered into an uncommitted $500 million accounts receivable repurchase facility (the “repurchase facility”), where we may sell certain receivables from customers to a financial institution and agree to repurchase those receivables at a future date. When we draw under this repurchase facility, the receivables from customers remain on our condensed consolidated balance sheet as we control and retain substantially all of the risks and rewards associated with the receivables. As at June 30, 2024, there were no borrowings made under this facility.

Note 8 Long-term debt

 

 Issuances in the second quarter of 2024

 

(millions of US dollars, except as otherwise noted)

   Rate of interest (%)        Maturity        Amount   

 Senior notes issued 2024

     5.2          June 21, 2027          400   

 Senior notes issued 2024

     5.4          June 21, 2034          600   
                             1,000   

The notes issued in the three and six months ended June 30, 2024, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance of common shares, debt securities and other securities during a period of 25 months from March 22, 2024.

Note 9 Seasonality

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. The results of this seasonality have a corresponding effect on receivables from customers and rebates receivables, inventories, prepaid expenses and other current assets, and trade payables. Our short-term debt also fluctuates during the year to meet working capital requirements. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

Note 10 Related party transactions

We sell potash outside Canada and the United States exclusively through Canpotex. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed upon prices. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex.

 

 As at (millions of US dollars)      June 30, 2024        December 31, 2023  

 Receivables from Canpotex

     206        162  

 

35


Unaudited  

 

Note 11 Accounting policies, estimates and judgments

IFRS 18, “Presentation and Disclosure in Financial Statements” (“IFRS 18”), which was issued on April 9, 2024, would supersede IAS 1, “Presentation of Financial Statements” and increase the comparability of financial statements by enhancing principles on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

Amendments for IFRS 9 and IFRS 7, “Amendments to the Classification and Measurement of Financial Instruments”, which was issued on May 30, 2024, will address diversity in practice by making the requirements more understandable and consistently applied. These amendments will be effective January 1, 2026, and will not apply to comparative information. We are reviewing the standard to determine the potential impact.

 

36